Symbiocaps LA, Lactobaccilus Acidophillus, encapsulated in biopolymer particles with a micrometric particle diameter. Encapsulation through the technology developed by Nanovetores allows the stabilization of sensitive, therefore, complex components to be formulated, providing the product with high efficacy and excellent probiotic and bio-booster effect in Skin restoration, Reducing oily skin, Reducing pores, Invigorating skin hydration, Preventing skin aging, Regulating skin microbiota and pH, Active protection against external aggressions, Contributes to acne treatment, and Reducing pores.
| Name (CAS Number) | |
|---|---|
| Alginic acid, sodium salt (9005-38-3) | Sign in to view |
| Calcium chloride (10043-52-4) | Sign in to view |
| Water (7732-18-5) | Sign in to view |
| 2,4-Hexadienoic acid, potassium salt, (2E,4E)- (24634-61-5) | Sign in to view |
| Sodium benzoate (532-32-1) | Sign in to view |
The following lists represent a selection of UL's ChemADVISOR™ Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
| Name (CAS Number) | |
|---|---|
|
2,4-Hexadienoic acid, potassium salt, (2E,4E)- (24634-61-5)
|
Sign in to view |
|
Alginic acid, sodium salt (9005-38-3)
|
Sign in to view |
|
Calcium chloride (10043-52-4)
|
Sign in to view |
|
Sodium benzoate (532-32-1)
|
Sign in to view |
|
Water (7732-18-5)
|
Sign in to view |
Nanovetores develops high performance encapsulated ingredients for the personal care industry using totally sustainable technology. Our active ingredients are protected, have better penetration into the skin, and total release control. We use our proprietary technology to encapsulate Vitamins, Acids, Essential Oils and other active ingredients, granting more efficacy to their usage.
The information presented here was acquired by UL from the producer of the product or material or original information provider. However, UL assumes no responsibility or liability for the accuracy of the information contained on this website and strongly encourages that upon final product or material selection information is validated with the manufacturer. This website provides links to other websites owned by third parties. The content of such third party sites is not within our control, and we cannot and will not take responsibility for the information or content.
Nanovetores makes their documentation available in the regions indicated below:
The following lists represent a selection of UL's ChemADVISOR™ Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
With a Premium Prospector account, view regulatory advisory and retailer compliance on an ingredients level for your material searches. The full set of lists reviewed have been curated by UL's LOLI Regulatory Database specific for Prospector. Upgrade today!
Lists combine the ease of Bookmarks with the versatility of Tags. Instead of one collection of bookmarked items, create as many collections, called "Lists," as you need.
Find the link to your List page in the user menu.
All Tags have been converted to separate Lists, and your bookmarked items have been saved to a "Bookmarks" List.
When you click the Add to List button, a dropdown of your existing Lists appears. Click the List name to which you want to add this product or formula.
You can also create a new List. Simply click "Create a New List" and enter a name.
When you define a new List, the current item is automatically added to it. You can add a product or formula to as many Lists as you need.
Easily see which Lists this item appears in, and quickly go to that List from the links that appear on the page.
We're sorry, but the industry you have selected is not currently available in your chosen language. You may choose a language below to continue to this industry or close this dialog above.
GDPR Notice: